A Review Study about the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania from 2010 to 2020.

Mehrizi, Tahereh Zadeh; Rezayat, Seyed Mahdi; Ardestani, Mehdi Shafiee; Shahmabadi, Hasan Ebrahimi; Ramezani, Amitis

Mehrizi, Tahereh Zadeh; Rezayat, Seyed Mahdi; Ardestani, Mehdi Shafiee; Shahmabadi, Hasan Ebrahimi; Ramezani, Amitis.

Afiliación

Mehrizi TZ; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran,Iran.
Rezayat SM; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran,Iran.
Ardestani MS; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran,Iran.
Shahmabadi HE; Department of Microbiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan,Iran.
Ramezani A; Department of Clinical Research, Pasteur Institute of Iran, Tehran,Iran.

Curr Drug Deliv ; 18(9): 1234-1243, 2021.

Article en En | MEDLINE | ID: mdl-33726648

Asunto(s)

Antiprotozoarios; Quitosano; Leishmania; Nanopartículas; Anfotericina B; Portadores de Fármacos

Palabras clave

Amphotericin B; in vivo; leishmaniasis; nanochitosan; toxicity; treatment.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas / Leishmania / Antiprotozoarios Idioma: En Revista: Curr Drug Deliv Asunto de la revista: FARMACIA / FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google